seri
substitut
arylalkyl
carbonyl
benzen
sulphon
acid
synthes
evalu
vitro
antimicrobi
activ
result
indic
compound
benzenesulfon
acid
benzenesulfon
acid
found
activ
one
qsar
investig
indic
multitarget
qsar
model
effect
describ
antimicrobi
activ
onetarget
qsar
model
mtqsar
model
indic
import
topolog
paramet
balaban
index
j
follow
electron
paramet
lumo
topolog
paramet
valenc
second
order
molecular
connect
index
c
v
describ
antimicrobi
activ
synthes
compound
increas
incid
infect
caus
rapid
develop
microbi
resist
known
antibiot
seriou
health
problem
number
factor
respons
mutat
microbi
genom
multidrugresist
microbi
strain
prolifer
necess
effect
therapi
stimul
research
design
synthesi
novel
antimicrobi
molecul
spite
nearli
three
decad
intens
research
toward
treatment
erad
hivaid
diseas
remain
global
health
problem
advent
highli
activ
antiretrovir
therapi
haart
mid
employ
variou
combin
revers
transcriptas
proteas
inhibitor
led
mark
improv
clinic
outcom
divers
drug
avail
clinician
substanti
improv
hiv
treatment
still
signific
challeng
remain
particular
concern
longterm
treatment
side
effect
emerg
drugresist
viral
strain
heterocycl
molecul
benzimidazol
isoster
indol
purin
nuclei
present
number
fundament
cellular
compon
bioactiv
compound
make
benzimidazol
molecul
endow
varieti
biolog
properti
studi
recent
literatur
reveal
benzimidazol
report
number
biolog
activ
viz
antivir
antifung
antihelmint
antiprotozo
psychotrop
antihiv
antitumor
antioxid
anticoagul
activ
inde
number
import
drug
use
differ
therapeut
area
contain
benzimidazol
ring
proton
pump
inhibitor
omeprazol
antihypertens
candesartan
telmisartan
antihistamin
astemizol
antihelmint
albendazol
mebendazol
well
sever
kind
still
investig
therapeut
agent
includ
antitumor
antivir
qsar
refer
disciplin
comput
chemistri
address
model
biolog
activ
chemic
reactiv
base
quantit
descript
chemic
structur
molecul
qsar
reli
basic
assumpt
molecul
similar
physicochem
properti
structur
similar
activ
quantit
structureeact
relationship
qsar
one
import
area
chemometr
valuabl
tool
use
extens
drug
design
medicin
chemistri
reliabl
qsar
model
establish
predict
activ
molecul
know
structur
featur
play
import
role
biolog
process
bear
result
mind
continu
research
effort
search
novel
antivir
agent
herebi
present
synthesi
antimicrobi
antivir
activ
qsar
model
substitut
arylalkyl
carbonyl
benzenesulfon
acid
synthesi
compound
follow
gener
pathway
elicit
scheme
key
intermedi
benzenesulfon
acid
prepar
condens
benzimidazol
aryldiazonium
chlorid
acid
turn
prepar
diazot
acid
howev
base
experi
applic
cupric
chlorid
condens
aryldiazonium
chlorid
benzimidazol
suggest
dahiya
pathak
result
resin
sticki
product
therefor
coupl
carri
use
sodium
acet
along
stir
cold
condit
initi
h
follow
h
stir
room
temperatur
result
solid
product
synthesi
substitut
arylalkyl
carbonyl
benzenesulfon
acid
key
intermedi
benzenesulfon
acid
react
correspond
arylalkyl
acid
chlorid
form
reaction
correspond
arylalkyl
acid
thionyl
chlorid
import
note
yield
synthes
benzimidazol
low
yield
synthet
compound
may
attribut
one
follow
reason
reaction
may
revers
posit
equilibrium
unfavor
product
b
incurs
side
reaction
lead
format
byproduct
c
prematur
workup
reaction
complet
volatil
product
reaction
workup
e
loss
product
due
incomplet
extract
ineffici
crystal
workup
procedur
f
presenc
contamin
reactant
reagent
lead
less
effici
reaction
physicochem
characterist
synthes
compound
present
tabl
structur
compound
assign
ir
h
nmr
spectroscop
data
consist
propos
molecular
structur
primari
amino
group
compound
depict
presenc
nh
asymmetr
stretch
cm
ir
bend
vibrat
correspond
och
compound
appear
cm
presenc
heterocycl
pyridin
moieti
compound
demonstr
presenc
ch
plane
bend
cm
presenc
addit
sen
stretch
cm
apart
asymmetr
stretch
region
cm
indic
compound
contain
link
n
benzimidazol
appear
c
stretch
rang
cm
indic
format
tertiari
amid
reaction
acid
chlorid
benzenesulfon
acid
format
tertiari
amid
evidenc
absenc
ir
band
cm
cm
correspond
alkyl
aryl
acid
respect
appear
asymmetr
stretch
region
cm
demonstr
presenc
h
group
benzenesulfon
acid
attach
posit
benzimidazol
appear
singlet
around
ppm
correspond
proton
h
nmr
compound
indic
presenc
para
sulfonyl
phenyl
nucleu
posit
synthes
benzimidazol
multiplet
correspond
chlorid
methacryl
acid
coupl
constant
valu
hz
compound
indic
natur
doubl
bond
synthes
compound
tran
natur
compound
show
singlet
ppm
correspond
proton
och
confirm
attach
para
methoxi
benzoyl
group
n
posit
benzimidazol
absenc
singlet
ppm
nmr
spectra
compound
indic
absenc
free
cooh
group
confirm
compound
tertiari
amid
physic
mixtur
arylalkyl
acid
benzenesulfon
acid
therefor
assur
reaction
arylalkyl
acid
chlorid
secondari
nitrogen
benzimidazol
nucleu
synthes
compound
evalu
vitro
antimicrobi
activ
two
gramposit
bacteria
e
staphylococcu
aureu
bacillu
subtili
gramneg
bacterium
e
escherichia
coli
fungal
strain
e
aspergillu
niger
candida
albican
tube
dilut
method
use
ciprofloxacin
fluconazol
control
drug
antibacteri
antifung
activ
respect
result
antimicrobi
studi
present
tabl
gener
compound
show
improv
antibacteri
activ
compar
antifung
activ
deduc
pattern
antimicrobi
activ
synthes
benzimidazol
follow
order
antibacteri
activ
antifung
activ
compound
effect
compound
aureu
pmicsa
valu
tabl
respect
activ
b
subtili
compound
yield
better
activ
tabl
respect
discuss
evid
compound
emerg
activ
antibacteri
benzimidazol
compound
emerg
effect
antifung
agent
c
albican
wherea
compound
activ
niger
tabl
discuss
evid
compound
emerg
effect
antifung
benzimidazol
minimum
bactericid
concentrationminimum
fungicid
concentr
mbcmfc
tabl
determin
result
reveal
synthes
compound
fungistat
fungi
bacteriostat
aureu
b
subtili
bacteriocid
e
coli
gener
mbc
mfc
synthes
benzimidazol
deriv
higher
mic
valu
indic
bacteriostat
fungistat
action
except
e
coli
drug
consid
bacteriosaticfungistat
mbc
mfc
valu
higher
mic
valu
case
aureu
compound
bacillu
subtitli
compound
found
activ
bacteriocid
agent
order
understand
experiment
antimicrobi
data
theoret
basi
establish
quantit
structur
activ
relationship
qsar
vitro
antimicrobi
activ
synthes
benzimidazol
deriv
descriptor
code
lipophil
electron
steric
topolog
properti
molecul
consider
use
linear
free
energi
relationship
model
lfer
describ
hansch
fujita
biolog
activ
data
determin
mic
valu
first
transform
pmic
valu
use
depend
variabl
qsar
studi
differ
molecular
descriptor
independ
variabl
like
log
octanolwat
partit
coeffici
log
p
molar
refract
mr
kier
molecular
connect
c
c
v
c
c
v
c
c
v
shape
k
ka
topolog
indic
randic
topolog
index
r
balaban
topolog
index
j
wiener
topolog
index
w
total
energi
te
energi
highest
occupi
molecular
orbit
homo
lowest
unoccupi
molecular
orbit
lumo
dipol
moment
electron
energi
ele
nuclear
energi
nue
molecular
surfac
area
sa
calcul
substitut
arylalkyl
carbonyl
benzenesulfon
acid
use
independ
variabl
present
tabl
present
studi
data
set
benzimidazol
deriv
subject
linear
free
energi
regress
analysi
model
gener
refer
drug
includ
model
develop
belong
differ
structur
seri
preliminari
analysi
carri
term
correl
analysi
correl
matrix
construct
antibacteri
activ
aureu
present
tabl
correl
differ
molecular
descriptor
antimicrobi
activ
present
tabl
gener
high
colinear
r
observ
differ
paramet
high
interrelationship
observ
te
nue
r
low
interrelationship
observ
c
v
lumo
r
correl
matrix
tabl
indic
import
topolog
paramet
balaban
index
j
describ
antibacteri
activ
synthes
benzimidazol
deriv
aureu
otqsar
model
antibacteri
activ
aureu
thereaft
n
e
number
data
point
r
e
correl
coeffici
q
e
cross
valid
r
obtain
leav
one
method
e
standard
error
estim
f
e
fischer
statist
coeffici
j
eq
neg
therefor
antibacteri
activ
aureu
increas
decreas
valu
j
clearli
evid
tabl
tabl
minimum
antibacteri
activ
aureu
addit
electron
paramet
energi
lowest
unoccupi
molecular
orbit
lumo
balaban
index
eq
improv
correl
r
eq
otqsar
model
antibacteri
activ
aureu
result
indic
antibacteri
activ
synthes
benzimidazol
deriv
determin
mainli
topolog
paramet
balaban
index
j
follow
electron
paramet
lumo
topolog
paramet
valenc
second
order
molecular
connect
index
c
v
qsar
model
express
eq
cross
valid
appreci
q
valu
q
obtain
leav
one
loo
method
valu
q
greater
basic
requir
qualifi
qsar
model
valid
one
comparison
observ
predict
antimicrobi
activ
present
tabl
seen
result
observ
predict
antimicrobi
activ
lie
close
evidenc
low
residu
valu
plot
predict
pmicsa
observ
pmic
sa
fig
also
favor
model
express
eq
plot
observ
pmic
sa
vs
residu
pmic
sa
fig
indic
system
error
model
develop
propag
residu
observ
posit
neg
side
mlr
eq
e
develop
predict
antimicrobi
activ
benzimidazol
deriv
b
subtili
e
coli
c
albican
niger
otqsar
model
antibacteri
activ
b
subtili
otqsar
model
antibacteri
activ
e
coli
pmic
ec
c
v
j
lumo
otqsar
model
antifung
activ
c
albican
qsar
model
antifung
activ
niger
pmic
log
p
ne
case
aureu
mlr
equat
deriv
b
subtili
e
coli
also
indic
import
topolog
paramet
balaban
index
j
follow
electron
paramet
lumo
topolog
paramet
valenc
second
order
molecular
connect
index
c
v
describ
antibacteri
activ
b
subtili
e
coli
antifung
activ
c
albican
case
antifung
activ
benzimidazol
deriv
niger
mlr
equat
indic
import
lipophil
paramet
log
octanolewat
partit
coeffici
log
p
electron
paramet
nuclear
energi
nu
e
descript
activ
case
eq
predict
abil
eq
respect
microorgan
support
low
residu
activ
valu
tabl
high
q
valu
observ
also
support
suitabl
qsar
model
q
describ
eq
case
mlr
model
deriv
niger
q
valu
less
show
develop
model
invalid
one
one
forget
recommend
golbraikh
tropsha
report
way
estim
true
predict
power
qsar
model
test
abil
valid
one
import
note
equat
deriv
use
entir
data
set
outlier
data
set
gener
qsar
studi
biolog
activ
compound
span
order
magnitud
present
studi
rang
antimicrobi
activ
synthes
compound
within
one
order
magnitud
import
note
predict
qsar
model
develop
present
studi
highli
evidenc
low
residu
valu
accord
result
suggest
bajaj
et
al
state
reliabl
qsar
model
lie
predict
abil
even
though
activ
data
narrow
rang
recent
literatur
reveal
qsar
appli
describ
relationship
narrow
rang
biolog
activ
physicochem
properti
molecul
biolog
activ
data
lie
narrow
rang
presenc
minimum
standard
deviat
biolog
activ
justifi
use
qsar
studi
minimum
standard
deviat
tabl
observ
antimicrobi
activ
data
justifi
use
qsar
studi
accord
otqsar
model
one
use
five
differ
equat
predict
activ
new
compound
five
microbi
speci
otqsar
model
almost
literatur
becom
unpract
complic
use
predict
compound
result
onetarget
case
develop
one
otqsar
target
howev
recent
interest
increas
develop
multitarget
qsar
mtqsar
model
opposit
otqsar
mtqsar
model
singl
equat
consid
natur
molecular
descriptor
common
essenti
describ
antimicrobi
activ
present
studi
attempt
develop
three
differ
type
mtqsar
model
viz
mtqsar
model
describ
antibacteri
activ
synthes
compound
aureu
b
subtili
e
coli
mtqsar
model
describ
antifung
activ
synthes
compound
c
albican
tabl
comparison
observ
predict
antibacteri
antifung
activ
obtain
otqsar
model
comp
pmicsa
eq
pmicb
eq
pmicec
eq
pmicca
eq
pmican
eq
niger
well
common
mtqsar
model
describ
antimicrobi
activ
synthes
benzimidazol
deriv
mention
microorgan
order
develop
mtqsar
model
calcul
averag
antibacteri
activ
pmic
b
pmic
sa
pmicb
pmicec
antifung
activ
pmic
f
pmic
ca
pmic
antimicrobi
activ
valu
pmic
pmic
sa
pmicb
pmic
ec
pmic
ca
pmic
benzimidazol
deriv
present
tabl
averag
activ
valu
also
correl
molecular
descriptor
synthes
compound
tabl
predict
eq
e
verifi
calcul
antibacteri
antifung
antimicrobi
activ
substitut
benzimidazol
respect
low
residu
activ
valu
indic
high
predict
mention
equat
tabl
plot
observ
pmicam
predict
pmicam
fig
also
favor
mtqsar
target
model
antimicrobi
activ
propag
activ
valu
side
zero
plot
observ
pmicam
residu
pmicam
indic
system
error
develop
mtqsar
model
fig
statist
signific
otqsar
mtqsar
model
deriv
present
tabl
balaban
index
j
variant
connect
index
repres
extend
connect
good
descriptor
shape
molecul
one
wide
use
topolog
indic
qsar
qspr
studi
balaban
index
connect
molecular
graph
g
defin
number
edg
cyclomat
number
u
sum
distanc
vertex
u
vertic
g
summat
goe
edg
edg
set
e
g
electron
paramet
lumo
denot
energi
lowest
unoccupi
molecular
orbit
directli
relat
electron
affin
character
sensibl
molecul
toward
attack
necleophil
contribut
lumo
describ
antimicrobi
activ
may
attribut
interact
benzimidazol
deriv
nucleophil
amino
acid
residu
like
cystein
microorgan
topolog
descriptor
ie
valenc
second
order
molecular
connect
index
encod
inform
relat
degre
stargraph
like
take
larg
valu
linear
molecul
trend
eq
indic
higher
valu
j
lumo
c
v
lower
antimicrobi
activ
benzimidazol
deriv
residu
activ
valu
case
mtqsar
model
antimicrobi
activ
less
compar
residu
onetarget
model
tabl
well
multitarget
model
antibacteri
antifung
activ
tabl
mtqsar
equat
eq
use
predict
activ
substitut
benzimidazol
differ
microbi
speci
furthermor
topolog
paramet
balaban
index
j
follow
electron
paramet
lumo
topolog
paramet
valenc
second
order
molecular
connect
index
c
v
describ
antimicrobi
activ
substitut
arylalkyl
carbonyl
benzenesulfon
acid
import
mention
develop
multiqsar
target
model
exhibit
follow
advantag
onetarget
qsar
model
improv
statist
paramet
compar
onetarget
model
improv
r
etc
cf
eq
eq
e
b
chang
trend
molecular
descriptor
observ
ie
three
paramet
ie
j
lumo
c
v
show
neg
correl
antimicrobi
activ
observ
case
onetarget
model
c
signific
decreas
residu
valu
compar
residu
valu
observ
onetarget
qsar
model
ie
mtqsar
model
better
predict
otqsar
model
regress
analysi
qualiti
correl
model
antibacteri
antifung
activ
synthes
benzimidazol
deriv
broad
antivir
screen
substitut
arylalkyl
carbonyl
benzenesulfon
acid
perform
varieti
dna
rna
virus
tabl
none
compound
inhibitori
virusinduc
cytopath
subtox
concentr
result
antimicrobi
antivir
activ
follow
structur
activ
relationship
drawn
result
antibacteri
activ
indic
compound
benzenesulfon
acid
effect
three
bacteri
speci
test
may
due
presenc
electron
withdraw
nitro
group
role
electron
withdraw
group
increas
antimicrobi
activ
similar
result
sharma
et
al
result
antifung
activ
indic
compound
benzenesulfon
acid
effect
test
fungal
strain
comparison
effect
antibacteri
antifung
compound
gave
inform
aromat
acid
substitut
n
benzimidazol
requir
antibacteri
activ
aliphat
acid
substitut
n
benzimidazol
requir
antifung
activ
indic
differ
structur
requir
essenti
bind
drug
bacteri
fungal
target
respect
none
compound
endow
antivir
activ
subtox
concentr
seri
substitut
arylalkyl
carbonyl
benzenesulfon
acid
synthes
reaction
benzenesulfon
acid
correspond
arylalkyl
acid
chlorid
synthes
compound
character
physicochem
spectral
mean
ir
nmr
spectral
data
found
agreement
assign
molecular
structur
synthes
compound
evalu
vitro
antimicrobi
activ
bacteri
strain
aureu
b
subtili
e
coli
fungal
strain
e
niger
c
albican
tube
dilut
method
antimicrobi
screen
result
indic
compound
benzenesulfon
acid
benzenesulfon
acid
activ
one
antivir
evalu
reveal
specif
antivir
activ
test
compound
qsar
studi
carri
find
relationship
physicochem
paramet
antimicrobi
activ
benzimidazol
deriv
indic
import
topolog
paramet
balaban
index
acid
mol
hydrochlor
acid
water
mixtur
diazot
use
solut
sodium
nitrit
c
diazot
mixtur
benzimidazol
mol
ad
vigor
shake
solut
sodium
acet
g
ml
ad
drop
wise
mixtur
maintain
temperatur
c
solut
stir
initi
h
cold
condit
follow
continu
stir
room
temperatur
h
product
benzenesulfon
acid
obtain
filter
dri
recrystal
use
alcohol
solut
benzenesulfon
acid
mol
diethyl
ether
ml
ad
solut
acid
chlorid
anthranil
acid
mol
diethyl
ether
ml
mixtur
stir
h
room
temperatur
result
product
benzenesulfon
acid
isol
evapor
ether
purifi
recrystallis
methanol
compound
synthes
similar
procedur
follow
compound
use
correspond
arylalkyl
acid
chlorid
benzenesulfon
acid
structur
substitut
benzimidazol
deriv
first
preoptim
molecular
mechan
forc
field
procedur
includ
hyperchem
result
geometri
refin
mean
semiempir
method
parametr
chose
gradient
norm
limit
kcala
geometri
optim
lowest
energi
structur
use
molecul
calcul
physicochem
properti
use
tsar
softwar
window
regress
analysi
perform
use
spss
softwar
packag
predict
power
equat
valid
leav
one
loo
cross
valid
method
model
built
compound
nth
compound
predict
compound
left
model
deriv
predict
turn
indic
perform
obtain
cross
valid
q
method
defin
predict
actual
mean
predict
actual
mean
valu
target
properti
pmic
respect
predict
actual
predict
residu
error
sum
squar
rod
cell
cultur
result
express
effect
concentr
ec
drug
concentr
requir
inhibit
virusinduc
cytopath
readout
microscop
inspect
mt
viabil
stain
method
cell
grown
plate
infect
ccid
viru
one
ccid
cell
cultur
infect
dose
presenc
serial
dilut
compound
cultur
incub
c
sever
day
complet
cytopath
observ
infect
untreat
viru
control
cytotox
compound
evalu
parallel
antivir
activ
uninfect
cell
cultur
express
minimum
cytotox
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
hel
hela
crfk
mdck
vero
cell
